Viewing Study NCT05718232


Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2026-01-01 @ 10:02 PM
Study NCT ID: NCT05718232
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-02-08
First Post: 2023-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module